Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.
BCL6 promotes CCR2-driven CNS infiltration of encephalitogenic Th17 cells.
Guillain-Barré Polyradiculoneuritis Developed in the Context of Lyme Neuroborreliosis in a 13-Year-Old Girl: A Case Report.
Central Pontine Myelinolysis Leading to an Intensive Care Unit Admission.
Response to "comment on 'evidence for compromised function of the glymphatic system in pediatric acquired demyelinating disorders'".
Demyelination in Vascular Dementia: Focus on Oligodendrocytes, Microglia, and Their Interaction.
Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges.
Nervonic Acid from Reverses Parkinson's Disease by Regulating Oxidative Stress, Neuroinflammation, and Gut Microbiota.
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
[What do we know about compassion focused therapy for anxiety and depressive symptoms: A scoping review].
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.
Glial cells in chronic inflammation: diversity, dysfunction and therapeutic targeting.
Extracellular Vesicle-Associated IL4 Displays Enhanced Anti-Inflammatory Properties in Microglial Cells.
Head-To-Head Intra Individual Comparison of Three Therapeutic Apheresis Modalities in Chronic Auto-Immune Neuropathy: A Real-World Experience.
Association between Proteinuria and Risk of Chronic Inflammatory Demyelinating Polyneuropathy/Multifocal Motor Neuropathy: A Nationwide Population-based Cohort Study.
CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.
Acute Progressive Bilateral Lower Extremity Weakness & Paresthesia.
A Case of Advanced Charcot-Marie-Tooth Disease Showing Extreme Lumbosacral Nerve Root Hypertrophy.
Early treatment with ofatumumab increases the likelihood of stabilizing disease in patients with relapsing-remitting multiple sclerosis.
Neuroradiological patterns and prognostic implications in type I Alexander disease.
Case Report: Neuromyelitis optica spectrum disorder associated with gastric cardia and pancreatic cancers: clinical features and oncological implications.
Wilson's disease presenting as osmotic demyelination syndrome.
Exosomes: A new frontier in the treatment of neurological diseases.
Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations.
Pages
« first
‹ previous
…
1019
1020
1021
1022
1023
1024
1025
1026
1027
…
next ›
last »